GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Frontier Biotechnologies Inc (SHSE:688221) » Definitions » Selling and Marketing Expense

Frontier Biotechnologies (SHSE:688221) Selling and Marketing Expense : ¥41.5 Mil (TTM As of Sep. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Frontier Biotechnologies Selling and Marketing Expense?

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services. Frontier Biotechnologies's Selling and Marketing Expense for the three months ended in Sep. 2024 was ¥28.5 Mil. Its Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 was ¥41.5 Mil.

Frontier Biotechnologies Selling and Marketing Expense Historical Data

The historical data trend for Frontier Biotechnologies's Selling and Marketing Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Frontier Biotechnologies Selling and Marketing Expense Chart

Frontier Biotechnologies Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Selling and Marketing Expense
Get a 7-Day Free Trial 12.24 19.09 37.08 27.03 36.57

Frontier Biotechnologies Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Selling and Marketing Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.78 -6.39 16.80 2.59 28.54

Frontier Biotechnologies Selling and Marketing Expense Calculation

Selling and Marketing Expense is the aggregate total amount of expenses directly related to the marketing or selling of products or services.

Selling and Marketing Expense for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥41.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frontier Biotechnologies Selling and Marketing Expense Related Terms

Thank you for viewing the detailed overview of Frontier Biotechnologies's Selling and Marketing Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Frontier Biotechnologies Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Frontier Biotechnologies Inc (SHSE:688221) » Definitions » Selling and Marketing Expense
Comparable Companies
SHSE:688136 SZSE:301230 SHSE:688670 SZSE:300381 SZSE:002868 SZSE:300238 SZSE:300583 SHSE:688068 SZSE:000710 SZSE:300149 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
No. 5 Gande Road, 7th Floor, Science Park, Jiangning District, Jiangsu Province, Nanjing, CHN, 211122
Website
http://www.frontierbiotech.com
Frontier Biotechnologies Inc is an innovative biomedical company. It is engaged in the production and sales of innovative drugs for major unmet clinical needs. The company focuses on the research and development of new drugs in the field of long-acting peptides and differentiated product development strategies for unmet clinical and patient needs.

Frontier Biotechnologies Headlines

No Headlines